Moscow gains new leverage with coronavirus vaccine breakthroughEurope risks being caught short once again in its vaccine strategy.
When news broke last August that Russia was the first country to approve a vaccine against the coronavirus, it was met with raised eyebrows around the globe.
The shot — named Sputnik V — hadn’t gone through the standard testing regime. Experts warned that the rushed process risked undermining public confidence in the shot. Meanwhile, media reported that production snags were delaying its rollout.
Impressive late-stage clinical trial results published in one of the world’s most prestigious medical journals Tuesday, however, have provided a sought-after endorsement from the scientific community.
Please follow my Telegram Channel
https://t.me/IvankaTrump2024
